Skip to content

Breakthrough Improvement Collaborative for ColoRectal Cancer (BIC4CRC)

BIC4CRC: Breakthrough Improvement Collaborative for ColoRectal Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03320317
Acronym
BIC4CRC
Enrollment
950
Registered
2017-10-25
Start date
2018-03-30
Completion date
2025-12-01
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

Colorectal cancer is the most common cancer in Europe and the third worldwide. Approximately 1 in 20 men and 1 in 35 women will develop colorectal cancer at some moment in their life. In Flanders, in 2014, there was an increase in the detection of colorectal cancer with 21% compared to 2013. Early detection improves the prognosis for the patient. In this early stage, colorectal surgery is one of the most important treatments, but it is also complex and has a high complication rate. However, over the last decade, surgical care for patients with colorectal cancer has become more standardized. The use of structured care methods, such as care pathways and protocols, has helped in standardizing care processes. Specifically for patients with colorectal cancer, perioperative care has shifted with the implementation of Enhanced Recovery After Surgery (ERAS) programs. The goal of ERAS- protocols is to optimize the interventions during the perioperative hospitalization period and reduce postoperative complications. Despite the increasing evidence in favor of the use of these standardized protocols, adherence and implementation in daily practice remains challenging. The primary goal of this quality improvement project is to enhance the standardization of key interventions in the ERAS care process for patients undergoing colorectal surgery. Therefore, adherence to the ERAS-guidelines will be investigated and hospitals will receive feedback to set up improvement initiatives. Moreover, interactive group sessions and on-site training activities will stimulate knowledge sharing and define best practices.

Interventions

Learn form international report, Explain key interventions, Explain BIC methodology, Retrospective patient record analysis, Team measures

Feedback report, Share (inter)national best practices, Discussion, set priorities, teaching and improvement, Retrospective patient record analysis

Feedback report, Share best practices, Discussion, set priorities, teaching and improvement, Retrospective patient record analysis, Team measures

OTHERLearning session 4

Feedback report, Best practice symposium

Sponsors

Kom Op Tegen Kanker
CollaboratorOTHER
KU Leuven
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Minimum age of 18 years * Elective admission for colorectal cancer surgery

Exclusion criteria

* Emergency (not planned) admission for colorectal cancer surgery * Patients diagnosed with severe dementia or severe concomitant disease that may affect very short term outcome and hence influence deviations from standard acute care

Design outcomes

Primary

MeasureTime frameDescription
Length of staythrough study completion, an average of 4 monthsNumber of days in the hospital

Secondary

MeasureTime frameDescription
30-days readmission ratethrough study completion, an average of 4 monthsReadmission rate
Mortality ratethrough study completion, an average of 4 monthsMortality rate
Complication ratethrough study completion, an average of 4 monthsRe-intervention, wound complications, surgical site infection, anastomotic leak or stoma related complications

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026